Cost-utility analysis of palivizumab in Italy: results from a simulation model in the prophylaxis of respiratory syncytial virus infection (RSV) among high-risk preterm infants

• Glavni autori: Ravasio Roberto (Autor), Chirico Gaetano (Autor), Sbarigia Urbano (Autor)
• Format: Knjiga
• Izdano: BMC, 2009-02-01T00:00:00Z.
• Teme: article
• Online pristup: Connect to this object online.

<p>Abstract</p> <p>Introduction</p> <p>The aim of this study was to assess the cost-utility of palivizumab versus no prophylaxis in the prevention of respiratory syncytial virus infection among high-risk preterm infants.</p> <p>Methods</p> <p>We...